CFLT vs IMCR · rev $963.6M vs rev $222.6M
Confluent Inc (CFLT) versus Immunocore Holdings Ltd (IMCR) — a side-by-side from cached financials, not a winner call.
Confluent Inc (CFLT) is a software - infrastructure company listed on US.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Latest reported CFLT revenue for 2024-12-31 was $963.6M. Net income was -$345.1M. Revenue was up 24.0% from 2023-12-31 to 2024-12-31. CFLT currently screens at market cap $11.13B.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
CFLT currently screens at market cap $11.13B. IMCR currently screens at market cap $1.45B.
Not investment advice. Open the CFLT and IMCR stock pages for the full models.
Not investment advice.